Overview: Nortriptyline TestIntroduction: The Nortriptyline Test measures nortriptyline levels to monitor depression treatment, preventing mood swings or toxicity. Aligned with 2023 APA guidelines, it uses immunoassay for high specificity, supporting drug monitoring. This test is critical for guiding treatment adjustments, preventing toxicity, and improving outcomes in toxicology for patients receiving nortriptyline for depression or neuropathic pain.
Other Names: Nortriptyline Assay, Tricyclic Antidepressant Test.
FDA Status: Laboratory-developed test (LDT), meeting toxicology standards for diagnostic accuracy.
Historical Milestone: Nortriptyline monitoring began in the 1960s with antidepressant research. Immunoassay methods improved in the 2000s, enhancing detection sensitivity.
Purpose: Measures nortriptyline levels to monitor depression treatment, guides dosage adjustments, and prevents toxicity.
Test Parameters: 1. Nortriptyline Level
Pretest Condition: No fasting required. Collect serum or plasma. Report history of depression, mood swings, or nortriptyline use.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document depression, mood swings, neuropathic pain, or history of antidepressant use. Include current medications, especially tricyclic antidepressants.
Consent: Written consent required, detailing the tests purpose, nortriptyline toxicity implications, and risks of blood collection.
Procedural Considerations: Uses immunoassay to measure nortriptyline levels in serum or plasma. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for antidepressant monitoring.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Drug interactions may alter levels.
Clinical Significance: Therapeutic nortriptyline levels support continued therapy, while elevated levels indicate toxicity, guiding dose adjustment. Low levels may require dose increase.
Specialist Consultation: Consult a psychiatrist or pharmacologist for result interpretation and treatment planning.
Additional Supporting Tests: ECG, liver function tests, or other antidepressant levels to monitor nortriptyline therapy.
Test Limitations: Levels vary with dosing schedule; clinical correlation is needed. Sample timing affects accuracy.
References: APA Depression Guidelines, 2023; Journal of Clinical Psychiatry, Thase ME, 2022.
